PCOS and Hyperprolactinemia: Conflicting Conditions or Comorbidities?
Currently, hyperprolactinemia is considered as a condition to be excluded during the diagnosis of polycystic ovarian syndrome (PCOS), because it often demonstrates clinical signs similar to PCOS. However, some publications have reported “the prevalence of hyperprolactinemia in PCOS,” which does not...
Main Authors: | Alina V. Atalyan, Eldar M. Sharifulin, Lyudmila M. Lazareva, Yana G. Nadelyaeva, Larisa V. Suturina |
---|---|
Format: | Article |
Language: | English |
Published: |
International Medical Research and Development Corporation
2021-12-01
|
Series: | International Journal of Biomedicine |
Subjects: | |
Online Access: | http://ijbm.org/articles/i44/ijbm_11(4)_br1.pdf |
Similar Items
-
CHARACTERISTICS OF PITUITARY-OPVARIAN-ADRENAL AXIS IN ADOLESCENT GIRLS WITH HYPERPROLACTINEMIA OF VARIOUS GENESIS
by: A. V. Labygina, et al.
Published: (2012-05-01) -
The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report
by: Larisa V. Suturina, et al.
Published: (2022-07-01) -
Hirsutism, Normal Androgens and Diagnosis of PCOS
by: Poli Mara Spritzer, et al.
Published: (2022-08-01) -
Effect of magnesium supplementation in improving hyperandrogenism, hirsutism, and sleep quality in women with polycystic ovary syndrome: A randomized, placebo‐controlled clinical trial
by: Mahsa Gholizadeh‐Moghaddam, et al.
Published: (2023-01-01) -
Clinico-pathological correlation in Indian women presenting with cutaneous features of hyperandrogenism: A cross-sectional study
by: Vikas Pathania, et al.
Published: (2020-01-01)